# A Registry-based Randomized Controlled Trial in Type 2 Diabetes With Cardiovascular Risk Factors (REMATCH)

> **NCT06627322** · NA · RECRUITING · sponsor: **Kyu Chang Won** · enrollment: 5950 (estimated)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** Dual-combination therapy
- **DRUG:** Triple-combination therapy
- **DEVICE:** Dexcom G7, Pasta

## Key facts

- **NCT ID:** NCT06627322
- **Lead sponsor:** Kyu Chang Won
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-21
- **Primary completion:** 2029-09-30
- **Final completion:** 2029-09-30
- **Target enrollment:** 5950 (ESTIMATED)
- **Last updated:** 2025-04-24

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06627322

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06627322, "A Registry-based Randomized Controlled Trial in Type 2 Diabetes With Cardiovascular Risk Factors (REMATCH)". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT06627322. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*